Biosimilars Key to Lowering Drug Prices; National Alliance of Healthcare Purchaser Coalitions Releases Playbook to Help Employers Adopt
To support plan sponsors in adopting biosimilars into their health and pharmacy benefit plans, the National Alliance of Healthcare Purchaser Coalitions (National Alliance) developed and released an employer playbook.
- To support plan sponsors in adopting biosimilars into their health and pharmacy benefit plans, the National Alliance of Healthcare Purchaser Coalitions (National Alliance) developed and released an employer playbook.
- "If properly managed, biosimilars can help employers save millions while increasing patient access," said Margaret Rehayem, vice president at National Alliance.
- "We are late in prioritizing biosimilar management," said Cathy Trinh, MS, senior healthcare analyst, SEIU 775 Benefits Group, and a participant in the biosimilars learning collaboratives.
- The National Alliance project brought together three member coalitions (Economic Alliance for Michigan, Florida Alliance for Healthcare Value and Washington Health Alliance) and eight employers of different sizes and industries to participate in the eight-month initiative.